Mr. Yang, 54, has felt more and more unclear eyes for more than a year, he naturally thought that this is the age of the eyes fading, but he found that his vision is declining rapidly, within a few months to change a pair of presbyopic glasses, in June this year he went to the hospital ophthalmology, the doctor found that he not only vision loss, but also a narrowing of the field of vision, so he was advised to go to brain surgery to take an MRI of the brain. MRI. When he got the MRI film to the brain surgeon, he was told that he had a pituitary tumor in his brain and that his blurry eyes were closely related to this pituitary tumor. The incidence of pituitary tumors is the same for men and women. The incidence of pituitary tumors is high, and more and more pituitary tumors are being detected due to the popularity of MRI testing. According to statistics, the incidence of pituitary tumors is 10%. However, the vast majority of people do not need treatment, and only a small percentage of them do. There is also a misconception that pituitary tumors are more common in women than in men, but in fact, a true screening will reveal that the incidence of pituitary tumors in men and women is the same and there is little difference. The reason for this misconception is that women will have symptoms such as menstrual disorders and nipple discharge, which will be easier to detect. Therefore, men should not ignore pituitary tumors either. Symptoms of pituitary tumors are more diverse The symptoms of pituitary tumors are very diverse, and readers should be more concerned about those that are not cerebral. Pituitary tumors can be divided into two categories, “non-secretory” and “secretory”, and their symptoms also differ depending on the nature of the tumor. pain on both sides of the temples. 2. Visual impairment is a common symptom of non-secretory pituitary tumor. After the tumor grows up, it compresses the optic nerve and causes visual impairment, which is a kind of progressive vision loss. It is easy to be ignored by patients, because older people think it is presbyopia and younger people think it is myopia. The visual impairment is also manifested in the reduction of the field of vision, but this change is generally ignored because people do not care. The reduction of the field of vision means that when the eyes look straight ahead, the range that can be seen by the afterglow of the eyes as we usually say is decreasing. 3. Endocrine symptoms Secretory pituitary tumors secrete hormones and cause many endocrine symptoms. (1) Secretion of prolactin, which can cause bad menstruation and nipple overflow in women and sexual dysfunction in men. (2) Secretion of growth hormone, which may cause excessive growth leading to gigantism in children and fingertip hypertrophy in adults, with relatively large changes in appearance, thicker lips, wider brain, very large fingers, and larger shoe sizes every year. (3) Secretion of cortisol, which manifests as full moon face, buffalo shoulder, and very obese. Treatment of pituitary tumors Not all pituitary tumors require treatment. This is because a significant proportion of pituitary tumors are very small and do not grow, and the patient has no symptoms and can be completely with the pituitary tumor as a normal person. If the pituitary tumor does not grow even after 3-5 years of observation, it is unlikely to grow in the future. However, all pituitary tumors with symptoms should be treated actively. If the pituitary tumor compresses the optic nerve at an advanced stage, the optic nerve will be atrophied and the eyes will only have light perception, so it will be almost impossible to recover the vision after treatment. Treatment is based on medication and surgery. Medication is only suitable for prolactinoma, which is more sensitive to medication, and most people can resume menstruation, get pregnant and have children, and the tumor shrinks and becomes smaller. However, the vast majority of patients need to take medication for life and should not stop taking it on their own. Other types of pituitary tumors with symptoms should be removed surgically, and the surgery is mainly minimally invasive. There is almost no recurrence after surgery. In the treatment, it should be noted that radiotherapy treatment is not advocated now because it is found that the systemic hormone level will be very low after more than 5 years of radiotherapy, and the use of systemic hormone replacement therapy is very complicated and will greatly affect the quality of life for the patient.